Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/04/012980
CTRI/2018/04/012980
Completed
Phase 2

A Clinical Evaluation of Efficacy and Safety of AyuAsmo Capsules in Patients Suffering From Bronchial Asthma.

Welex Laboratories Pvt Ltd0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Bronchial Asthma

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- Bronchial Asthma
Sponsor
Welex Laboratories Pvt Ltd
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Welex Laboratories Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • •2\.Patients with diagnosis of bronchial asthma, for a period of at least 6 months prior to screening visit.
  • •3\.Patients not on continue use of inhalers bronchodilators.
  • •4\.Percentage FEV1 more than 50% of prediction (predicted values) on screening visit.
  • •5\.Subjects willing to give informed consent and ready to comply with the study protocol.

Exclusion Criteria

  • •1\.Known cases of severe/chronic diseases those interfere with study.
  • •2\.Known cases of active malignancy.
  • •3\.Subjects giving history of significant cardiovascular event less than 12 weeks prior to screening.
  • •4\.Known cases of chronic cardiac illnesses
  • •5\.Subjects having known chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
  • •6\.Subjects with uncontrolled diabetes and hypertension.
  • •7\.Subjects using any other investigational drug within 1 month prior to recruitment in this study.
  • •8\.Known hypersensitivity to any of the ingredients used in study drug.
  • •9\.Pregnant and Lactating females.
  • •10\.Subjects currently participating in any other clinical study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Effect of the test product in reducing dark spots
CTRI/2024/03/064874Hindustan Unilever Limited
Recruiting
Phase 2
Ayurvedic treatment of insufficient lactatioHealth Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
CTRI/2019/08/020579ICMR
Active, not recruiting
Phase 4
A study to evaluate the efficacy of Madhuyashti,Khadira and Shankha Bhasma on Acidity
CTRI/2018/05/013941Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital
Recruiting
Phase 2
Evaluation of Green Propolis as a oral Anti-inflammatory DrugHealthy volunteersSP5.001.047.138
RBR-9zmfs9Faculdade de Medicina de Ribeirão Preto - FMRP
Not yet recruiting
Phase 3
A CLINICAL STUDY TO EVALUATE THE EFFICACY OF AYU-ANO-D-GEL(LOCALLY) ALONG WITH HARITAKI CHURNA VATI (ORALLY) IN THEMANAGEMENT OF PARIKARTIKA W.S.R. TO FISSURE IN ANO.
CTRI/2024/07/070027Damini Raut